Hidehito HORINOUCHI
LightNews LightNews
banner
hhorinouchi.bsky.social
Hidehito HORINOUCHI
@hhorinouchi.bsky.social
120 followers 36 following 91 posts
Medical Oncologist, NCC Japan, JCOG Lung Cancer Study Group, Education committee of JSMO, JLCS, @iaslc.bsky.social. @ascocancer.bsky.social FCOI http://bit.ly/3DBhVGE
Posts Replies Media Videos
hhorinouchi.bsky.social
🔥Oncology HERE & NOW Webcast/Podcast🆙
🚨 @realbowtiedoc.bsky.social & @crisbergerot.bsky.social
🎯 #SupportiveCare , the future of #Telemedicine
✅Japanese🇯🇵captions are available in #Youtube
youtu.be/4WYdTostU7w?...
@oncoalert.bsky.social
buzzsprout.com/1324033/epis...
March 30, 2025 at 10:11 AM
hhorinouchi.bsky.social
⏰NOW OUT‼️#ELCC25
🔥COCOON🦋: Preventing Moderate to Severe Dermatologic Adverse Events in 1st-line EGFR-mutant Advanced NSCLC Treated with Amivantamab + Lazertinib
🎙️ Dr. Nicolas Girard
🎯AEs ≥G2: OR 0.19 (95%CI, 0.09–0.40)
✅NCT06120140
#LCSM
@oncoalert.bsky.social
@myesmo.bsky.social
@iaslc.bsky.social
March 29, 2025 at 4:06 PM
hhorinouchi.bsky.social
⏰NOW OUT‼️ #ELCC25
🔥MARIPOSA🦋: Amivantamab plus lazertinib vs osimertinib in 1L EGFRm advanced NSCLC: Final OS
🎙️Prof. James Yang
🎯OS HR 0.75 (95%CI: 0.61-0.92)
🎯Seems like extending the OS for 1️⃣2️⃣ months
✅NCT04487080
#LCSM #EGFR
@oncoalert.bsky.social
@myesmo.bsky.social
@iaslc.bsky.social
March 26, 2025 at 5:27 PM
hhorinouchi.bsky.social
🌟 #JSMO25 🎌
🔥ctDNA-guided cancer therapy
🎙️ Dr. Jeanne Tie @petermaccc.bsky.social
🎯Adjuvant chemotherapy guided by circulating tumor DNA analysis in stage II colon cancer
@oncoalert.bsky.social
micenavi.jp/jsmo2025/sea...
March 11, 2025 at 3:16 PM
hhorinouchi.bsky.social
🌟 #JSMO25 🎌
🔥ctDNA-guided cancer therapy
🎙️ Dr. Yoshiaki Nakamura
🎯Beyond the Knife: ctDNA’s Promise in Post-Surgery Colorectal Cancer Management
@oncoalert.bsky.social
micenavi.jp/jsmo2025/sea...
March 11, 2025 at 3:13 PM
hhorinouchi.bsky.social
🌟 #JSMO25 🎌
🔥Education of Medical Oncologist @ APAC region
🎙️ Prof. Ichiro Kinoshita
🎯Educational initiative at Japanese Society of Medical Oncology
@oncoalert.bsky.social
micenavi.jp/jsmo2025/sea...
March 11, 2025 at 3:06 PM
hhorinouchi.bsky.social
🌟 #JSMO25 🎌
🔥Education of Medical Oncologist @ APAC region
🎙️ Prof. Chih-Hung Hsu, Taiwan Oncology Society (TOS)
🎯Oncology Education Initiatives in Taiwan Oncology Society
@oncoalert.bsky.social
micenavi.jp/jsmo2025/sea...
March 11, 2025 at 3:04 PM
hhorinouchi.bsky.social
🌟 #JSMO25 🎌
🔥Education of Medical Oncologist @ APAC region
🎙️ Dr. Eileen Poon
🎯Educational Initiatives of Singapore Society of Oncology
@oncoalert.bsky.social
micenavi.jp/jsmo2025/sea...
March 11, 2025 at 3:03 PM
hhorinouchi.bsky.social
🌟 #JSMO25 🎌
🔥Education of Medical Oncologist @ APAC region
🎙️ Prof. Yeon Hee Park
🎯Crisis in Medical Oncology Fellowship Education in Korea
@oncoalert.bsky.social
micenavi.jp/jsmo2025/sea...
March 11, 2025 at 3:02 PM
hhorinouchi.bsky.social
🌟 #JSMO25 🎌
🔥Education of Medical Oncologist @ APAC region
🎙️ Dr. Melissa Eastgate
🎯Medical Oncology Group of Australia
@oncoalert.bsky.social
micenavi.jp/jsmo2025/sea...
March 11, 2025 at 3:00 PM
hhorinouchi.bsky.social
🔜JOIN US🔥 #JSMO25
☑️Japanese Society of Medical Oncology
🎌JAPAN⚓️KOBE🥩OSAKA🏯KYOTO⛩️
🌟Precision Oncology Toward Practical Value for Patients
🗓️March 6-8, 2025
🎖️Congress President: Prof. Tetsuji Takayama
@oncoalert.bsky.social
site2.convention.co.jp/jsmo2025/eng...
February 18, 2025 at 3:26 PM
hhorinouchi.bsky.social
🔥 @jtoonline.bsky.social 🆙
✅Controversies in Thoracic Oncology
🎯1st line Tx for #ALK pts

🆗Lorlatinib🆗
🗣️Dr. Hui Jing Hoe @bensolomon1.bsky.social
t.co/PzKWydsEoX
◀️🆚▶️
🆖Multiple options🆖
🗣️ @vklam.bsky.social Dr. Shirish Gadgeel
t.co/KkAzCMWFyX

#LCSM @oncoalert.bsky.social @alkpositive.bsky.social
February 16, 2025 at 12:55 AM
hhorinouchi.bsky.social
🔥@jtoonline.bsky.social🆙
✅Controversies in Thoracic Oncology
🎯Adj ICI in pCR by Neo-ICI

🆗Adj ICI🆗
🗣️Dr. Dipesh Uprety @solangepeters.bsky.social
jto.org/article/S155...

◀️🆚▶️

🆖Adj ICI🆖
🗣️Dr. William Phillips @drcamidge.bsky.social
jto.org/article/S155...

#LCSM @oncoalert.bsky.social
January 15, 2025 at 11:16 AM
hhorinouchi.bsky.social
🫁Taiwan🇹🇼Association for the Study of Lung Cancer
🎯 #TASLC25 International Symposium
🎖️Chair: Prof. James Yang
🌟Faculties: Drs. David Gandara, Fred Hirsch, @solangepeters.bsky.social @bensolomon1.bsky.social Tony Mok, Daniel Tan, Justin Gainor, Martin Reck, Karen Kelly, and more
@oncoalert.bsky.social
January 10, 2025 at 2:18 PM
hhorinouchi.bsky.social
🔥Lung Cancer🆙
✅Genomic analysis of comprehensive next generation sequencing data to explore the criteria for MET amplification as an actionable biomarker in NSCLC
👥David Chun Cheong Tsui @drcamidge.bsky.social
#LCSM @oncoalert.bsky.social #MET
www.lungcancerjournal.info/article/S016...
January 4, 2025 at 2:22 PM
hhorinouchi.bsky.social
🔥Lung Cancer🆙
✅Asian Thoracic Oncology Research Group #ATORG expert consensus statement on the peri-operative management of NSCLC
👥Dr. Stephanie Saw
#LCSM @oncoalert.bsky.social
www.lungcancerjournal.info/article/S016...
January 3, 2025 at 12:28 PM
hhorinouchi.bsky.social
🔥@iaslc.bsky.social @jtoonline.bsky.social🆙
✅NORA: Neoadj and adj osimertinib in stage IA-IIIA, EGFR-m NSCLC
🎯MPR 24% / PCR 0% with exploratory MRD (Signatera) analysis
👥Drs. Jii Bum Lee, Sun Min Lim, Min Hee Hong and Byoung Chul Cho
#LCSM @oncoalert.bsky.social #LiquidBiopsy
jto.org/article/S155...
January 3, 2025 at 12:19 PM